A truly groundbreaking study showcasing the transformative potential of human glial chimeric brain models for in vivo AAV evolution. Combining human glia-selective capsids with glymphatic delivery represents a landmark advance toward precise CNS gene therapy!
Efficient targeting of human glial progenitor cells in vivo with engineered AAV vectors and glymphatic delivery - @urmed.bsky.social @ucph.bsky.social www.nature.com/articles/s41...